X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Pelican BioThermal Opens Dublin Network Station & Service Center

Content Team by Content Team
6th March 2019
in Packaging & Logistic, Press Statements
Pelican BioThermal Opens Dublin Network Station & Service Center

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Pelican BioThermal, the global name in temperature controlled packaging, announces the opening of a new network station and service center in Dublin, Ireland to service, refurbish, repair and condition Pelican BioThermal’s reusable Cr?do on Demand shippers. This new facility puts Pelican BioThermal on track to realize its plan to exceed 100 network stations and drop points for its rental program in 2019.

The Dublin facility is focused on Pelican BioThermal’s Cr?do on Demand program, which provides a high performance, flexible rental option for temperature controlled containers such as Cr?do Cargo, Cr?do™ Xtreme and Cr?do™ Cube. The Cr?do on Demand rental program allows organizations to choose the shipper application that best fits their company’s requirements, logistics profile and budget.

The new Dublin network station and service center is strategically located in Harristown, next to Dublin Airport, and is ideally located to serve the ever-growing pharma industry in Ireland, which is home to some of the world’s leading biotech and pharma companies.

All of the world’s top 10 biopharmaceutical companies and 14 of the world’s top 15 medical technology companies have operations in Ireland according to IDA Ireland (Investment Development Agency), which highlighted how 75 pharmaceutical companies operate in the country where the biopharmaceutical industry has made a capital investment of approximately $10 billion in new facilities during recent years. IDA Ireland added this represents close to the biggest wave of investment in new biotech facilities anywhere in the world. and how Ireland’s pharma, bio and chemistry produce amounts to €39 billion in annual exports.

Dublin is a key hub of manufacturing and distribution for the pharma industry and Ireland is home to some of the largest pharmaceutical and healthcare companies in the world including Lilly, Pfizer, Sanofi, Amgen, Allergan, Alexion, GlaxoSmithKline, Merck and Pramerica.

“Dublin is a key logistics location hub and Ireland’s life sciences sector and bio-pharmaceutical industry is increasing at a rapid rate,” said Dominic Hyde, Pelican BioThermal’s vice president of Cr?do™ on Demand. “As we continue to expand our Cr?do on Demand rental program, the Dublin network station and service center puts customers in closer proximity to more convenient and flexible shipping options.”

The Dublin network station and service center is being staffed by a team of Pelican BioThermal experts to mirror the superior service levels provided at the company’s growing number of network stations and service centers around the globe.

Pelican BioThermal is a division of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.

About Pelican Products
Pelican Products, Inc. is the global leader in the design and manufacture of high performance protective cases, temperature controlled packaging solutions, advanced portable lighting systems and rugged gear for professionals and outdoor enthusiasts. Their products are used by professionals in the most demanding markets including fire safety, law enforcement, defense / military, aerospace, entertainment, industrial and consumer. Pelican™ products are designed and built to last a lifetime. The company operates in 21 countries, with 22 international sales offices and six manufacturing facilities around the globe. In Europe, the company does business under the name Peli Products, S.LU. For more information, visit www.pelican.com or www.behrmancap.com

About Pelican BioThermal
Pelican BioThermal LLC offers the widest range of thermally protected, temperature-controlled packaging and service solutions to the global life sciences industry. The company’s products ensure that delicate biological materials arrive intact and effective, despite exterior environments. Pelican BioThermal is dedicated to developing innovative products designed to fulfill the complex needs of the global life sciences industry. The company’s efforts have received recognition including the U.S. Army’s Greatest Inventions and the Made in Minnesota Manufacturing award for supply chain innovators. The company’s customers benefit from its extensive expertise in ensuring that temperature stability is maintained throughout the distribution chain. The company also offers a complete portfolio of services and software to support end-to-end temperature-controlled packaging asset management. In Europe, the company does business under the name Peli BioThermal Limited. For more information, visit pelicanbiothermal.com

Previous Post

The first WuXi Healthcare Forum opens in Shanghai

Next Post

Aprecia and CMIC have established an agreement to bring 3DP pharmaceutical products to Japan

Related Posts

Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Avadel Pharmaceuticals Receives
Drug Development

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

9th June 2025
ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
Press Statements

APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Next Post
Aprecia and CMIC have established an agreement to bring 3DP pharmaceutical products to Japan

Aprecia and CMIC have established an agreement to bring 3DP pharmaceutical products to Japan

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In